Variant report
Variant | nsv428748 |
---|---|
Chromosome Location | chr3:163767546-163809026 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532895942 | chr3:163767551-163767552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147829492 | chr3:163767553-163767554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371168089 | chr3:163767566-163767567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529167170 | chr3:163767651-163767652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115597128 | chr3:163767653-163767654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140365695 | chr3:163767655-163767656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6770461 | chr3:163767734-163767735 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs111425780 | chr3:163767763-163767764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6770474 | chr3:163767788-163767789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs570093304 | chr3:163767821-163767822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188956233 | chr3:163767826-163767827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs77486009 | chr3:163767865-163767866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551091662 | chr3:163767927-163767928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539967771 | chr3:163767937-163767938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553593916 | chr3:163768049-163768050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567064131 | chr3:163768053-163768054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372504437 | chr3:163768056-163768057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556044151 | chr3:163768096-163768097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575092355 | chr3:163768101-163768102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543787883 | chr3:163768107-163768108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549869426 | chr3:163768125-163768126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557357013 | chr3:163768126-163768127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577317958 | chr3:163768143-163768144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145698323 | chr3:163768144-163768145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560051548 | chr3:163768165-163768166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529090950 | chr3:163768170-163768171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568016616 | chr3:163768173-163768174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148941385 | chr3:163768191-163768192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562817724 | chr3:163768221-163768222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531671684 | chr3:163768340-163768341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550972615 | chr3:163768355-163768356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114827990 | chr3:163768362-163768363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533423574 | chr3:163768367-163768368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs36078312 | chr3:163768383-163768384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397875886 | chr3:163768392-163768393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573625405 | chr3:163768398-163768399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547118192 | chr3:163768407-163768408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145686497 | chr3:163768459-163768460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375630009 | chr3:163768484-163768485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192446995 | chr3:163768485-163768486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201740013 | chr3:163768493-163768494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555714977 | chr3:163768496-163768497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374886423 | chr3:163768497-163768498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569510781 | chr3:163768512-163768513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs13062385 | chr3:163768549-163768550 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs371245936 | chr3:163768671-163768672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557324055 | chr3:163768707-163768708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11367882 | chr3:163768739-163768740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs398082613 | chr3:163768740-163768741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs397876274 | chr3:163768741-163768742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163758400-163771800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:163764000-163768000 | Weak transcription | Placenta | Placenta |
3 | chr3:163768000-163768200 | Enhancers | Placenta | Placenta |
4 | chr3:163771800-163795600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:163795600-163796000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr3:163796000-163797400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:163797400-163798800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:163798800-163803400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:163803400-163804400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:163804400-163805400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:163805400-163806800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:163806800-163811400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |